Shares of Symphony Environmental Technologies PLC (LON: SYM) soared 23.8% today after the company presented an impressive set of results for its antiviral gloves and masks.
In particular, the d2pAM glove showed a 99.99% virus-reduction after only one hour of contact, the data shows. Similarly, the facemask showed a 99% virus-reduction after an hour and 99.9% after two hours.
“These test results are a significant step forward in our global marketing campaign to promote the importance of using our d2p technology in these everyday essential products,” Symphony chief executive, Michael Laurier said.
Interested in investing after today’s move?
XTB gives investors access to thousands of UK and international stocks,
including fractional shares from just £1.
Explore stocks with XTB →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
Want to invest in the stocks making the news?
Go from following the market to investing in it, with access to thousands
of stocks across major UK and international markets.
See available stocks →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
Own the stocks you’re reading about
Invest in real shares across the UK, US and other major global markets
through XTB, all from one investment account.
Explore XTB shares →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
You don’t need to buy a whole share
Fractional shares let you invest from just £1, giving you more control
over how much you put into individual companies.
Explore fractional shares →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
Want to see how XTB works first?
Explore the platform with an XTB demo account before deciding whether
you want to invest with real money.
Try the XTB demo →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
“We believe this is a major breakthrough in the fight against COVID. These masks and gloves will provide essential additional protection for everyone, especially for staff, patients, and visitors in a hospital or care-home environment.”
Symphony used the Laboratory of Virology at the University of Campinas in Brazil for testing its gear against the family of viruses, namely SARS-CoV-1, SARS-CoV-2/COVID-19 and MERS.
Symphony share price initially skyrocketed nearly 24% to hit a one-month high at 26p. The price action now trades at 22.6p, up 7.14%.
PEOPLE WHO READ THIS ALSO VIEWED:
